Inventor · disambiguated record
Shaun R. Stauffer
Also filed as: STAUFFER SHAUN · STAUFFER SHAUN R
37 granted patents·15 pending applications·59 citations·filing 2001–2023
95Inventor score
Files withUNIV VANDERBILT21CONN P JEFFREY8CLEVELAND CLINIC FOUND6MERCK & CO INC3MERCK SHARP & DOHME3
Top patents by PatentIndex Score
52 records- 0190US9212180B2Menin-MLL inhibitors and methods of use thereofUNIV MICHIGAN·Filed 2014·Granted Dec 15, 2015·11 cites·19 claims
- 0287US10160763B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2017·Granted Dec 25, 2018·5 cites·21 claims
- 0384US10844044B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Nov 24, 2020·4 cites·20 claims
- 0484US10501466B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2018·Granted Dec 10, 2019·3 cites·20 claims
- 0580US8592422B2Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptorsCONN P JEFFREY·Filed 2011·Granted Nov 26, 2013·5 cites·12 claims
- 0679US9540371B2Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1UNIV VANDERBILT·Filed 2014·Granted Jan 10, 2017·2 cites·12 claims
- 0778US10807959B2WDR5-MLL1 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Oct 20, 2020·2 cites·18 claims
- 0876US9527834B2Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2014·Granted Dec 27, 2016·1 cites·16 claims
- 0975US2024108591A1Or2l13 agonists to treat cvd with dysregulated platelet activationCLEVELAND CLINIC FOUND·Filed 2023·Application pending·0 cites
- 1073US9708278B2Substituted 4-benzyl-3,4-dihydro-2H-benzo[B][1,4]oxazine-2-carboxamide analogs as positive allosteric modulators of muscarinic acetycholine receptor M1UNIV VANDERBILT·Filed 2014·Granted Jul 18, 2017·1 cites·20 claims
- 1173US9238647B2P2X3 receptor antagonists for treatment of painBURGEY CHRISTOPHER S·Filed 2010·Granted Jan 19, 2016·4 cites·3 claims
- 1272US11999716B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Jun 4, 2024·1 cites·12 claims
- 1372US8703946B2Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptorsCONN P JEFFREY·Filed 2011·Granted Apr 22, 2014·2 cites·20 claims
- 1471US9090632B2Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptorsCONN P JEFFREY·Filed 2011·Granted Jul 28, 2015·1 cites·7 claims
- 1570US9255103B2Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulatorsUNIV VANDERBILT·Filed 2014·Granted Feb 9, 2016·1 cites·15 claims
- 1669US9572794B2Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonistsUNIV VANDERBILT·Filed 2015·Granted Feb 21, 2017·1 cites·27 claims
- 1769US8865725B2Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptorsCONN P JEFFREY·Filed 2012·Granted Oct 21, 2014·1 cites·12 claims
- 1869US8710074B2Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulatorsCONN P JEFFREY·Filed 2012·Granted Apr 29, 2014·2 cites·12 claims
- 1969US8211904B2Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's diseaseCOBURN CRAIG A·Filed 2006·Granted Jul 3, 2012·1 cites·17 claims
- 2068US9029366B2Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptorsUNIV VANDERBILT·Filed 2013·Granted May 12, 2015·1 cites·28 claims
- 2166US8901125B2Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptorsUNIV VANDERBILT·Filed 2013·Granted Dec 2, 2014·1 cites·20 claims
- 2266US8853237B2Naphthyridinone analogs as mGluR5 positive allosteric modulatorsCONN P JEFFREY·Filed 2011·Granted Oct 7, 2014·1 cites·12 claims
- 2366US8338614B2Tertiary carbinamines having substituted heterocycles which are active as β-secretase inhibitors for the treatment of alzheimer's diseaseMCGAUGHEY GEORGIA B·Filed 2006·Granted Dec 25, 2012·2 cites·7 claims
- 2465US7550481B2Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Jun 23, 2009·2 cites·21 claims
- 2565US7354942B2Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK & CO INC·Filed 2004·Granted Apr 8, 2008·3 cites·18 claims
- 2664US8969389B2Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulatorsCONN P JEFFREY·Filed 2011·Granted Mar 3, 2015·1 cites·4 claims
- 2757US2025241905A13-beta-hsd1 inhibitors and compositions and uses thereofCLEVELAND CLINIC FOUND·Filed 2023·Application pending·0 cites
- 2856US2025243196A1Citron kinase inhibitorsCLEVELAND CLINIC FOUND·Filed 2022·Application pending·0 cites
- 2956US2024293380A1Protease inhibitors and methods of useCLEVELAND CLINIC FOUND·Filed 2022·Application pending·0 cites
- 3055US2024239772A1Protease inhibitors and methods of useCLEVELAND CLINIC FOUND·Filed 2022·Application pending·0 cites
- 3152US2014329838A1Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptorsUNIV VANDERBILT·Filed 2014·Application pending·0 cites
- 3249US8377954B2Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK SHARP & DOHME·Filed 2007·Granted Feb 19, 2013·0 cites·6 claims
- 3349US2014057870A1Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptorsUNIV VANDERBILT·Filed 2013·Application pending·0 cites
- 3448US12384751B2Allosteric activators of the ALPHA1A-adrenergic receptorCLEVELAND CLINIC FOUND·Filed 2020·Granted Aug 12, 2025·0 cites·20 claims
- 3546US12398097B2WDR5-MYC inhibitorsUNIV VANDERBILT·Filed 2020·Granted Aug 26, 2025·0 cites·18 claims
- 3646US2010298342A1Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's DiseaseMERCK & CO INC·Filed 2007·Application pending·0 cites
- 3745US2013345204A1Substituted bicyclic cycloalkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptorsUNIV VANDERBILT·Filed 2013·Application pending·0 cites
- 3845US2013345205A1Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptorsUNIV VANDERBILT·Filed 2013·Application pending·0 cites
- 3944US7820674B2Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2006·Granted Oct 26, 2010·0 cites·17 claims
- 4044US2013252943A1Bicyclic oxazole lactams as allosteric modulators of mglur5 receptorsUNIV VANDERBILT·Filed 2013·Application pending·0 cites
- 4143US8399473B2Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's diseaseNANTERMET PHILIPPE G·Filed 2007·Granted Mar 19, 2013·0 cites·17 claims
- 4242US8143405B2Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's diseaseSTAUFFER SHAUN R·Filed 2007·Granted Mar 27, 2012·0 cites·21 claims
- 4342US7968571B22,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's DiseaseMERCK SHARP & DOHME·Filed 2005·Granted Jun 28, 2011·0 cites·12 claims
- 4441US8114887B2Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's diseaseBARROW JAMES C·Filed 2005·Granted Feb 14, 2012·0 cites·11 claims
- 4540US8293759B2Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's diseaseSTAUFFER SHAUN R·Filed 2007·Granted Oct 23, 2012·0 cites·10 claims
- 4640US2015216863A1Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptorsUNIV VANDERBILT·Filed 2015·Application pending·0 cites
- 4739US9963466B2Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonistsUNIV VANDERBILT·Filed 2017·Granted May 8, 2018·0 cites·25 claims
- 4837US8394837B22,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's diseaseNANTERMET PHILIPPE G·Filed 2005·Granted Mar 12, 2013·0 cites·14 claims
- 4936US7847100B21,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's diseaseMERCK SHARP & DOHME INC·Filed 2005·Granted Dec 7, 2010·0 cites·11 claims
- 5036US2011183980A1O-benzyl nicotinamide analogs as mglur5 positive allosteric modulatorsCONN P JEFFREY·Filed 2010·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shaun R. Stauffer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →